Abiopharma

🔍 Kiai Parsa (Director)

Company: MEDIFAST INC (MED)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 4,211 shares of Common Stock at $11.9996 per share (Direct)
  Date: 2026-08-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 665,517.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 118 shares of Common Stock at $11.9996 per share (Direct)
  Date: 2026-08-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 19,095.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
• F2: Ownership of Steamboat Capital Partners II, LP (II).
• F3: Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
• F4: This is an average price. Actual prices paid for the shares purchased on 8/24/26 and reported on this line range from $11.99 to $12. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.